论文部分内容阅读
目的 :观察新达罗 (国产头孢克罗 )治疗肺部感染的疗效 ,并与头孢拉定进行比较。方法 :112例肺部感染患者随机分为A组 ( 64例 )和B组 ( 4 8例 ) ,A组用新达罗胶囊 ,0 .5 g/次 ,tid ,疗程 7～ 14d ;B组用头孢拉定胶囊 ,0 .5 g/次 ,tid ,疗程 7～ 14d。结果 :A ,B两组临床有效率分别为 87.5 %和 72 .9% (P <0 .0 5 ) ,细菌清除率分别为86.7%和 70 .0 % (P <0 .0 5 ) ,两者之间有显著性差异 ,不良反应轻微。结论 :新达罗治疗肺部感染疗效及细菌清除率优于头孢拉定。
OBJECTIVE: To observe the efficacy of nedaloclo (domestic cefaclor) in the treatment of pulmonary infection and compare with cefradine. Methods: One hundred and twelve patients with pulmonary infection were randomly divided into group A (64 cases) and group B (48 cases). Group A was treated with nedalocrocaine capsules at 0. 5 g / tid for 7 to 14 days. Group B With cephradine capsules, 0 .5 g / time, tid, treatment 7 ~ 14d. Results: The clinical efficacies in group A and group B were 87.5% and 72.9%, respectively (P <0. 05), and the bacterial clearance rates were 86.7% and 70.0% (P <0.05), respectively There was a significant difference between the patients with mild adverse reactions. Conclusion: The effect of nedalus on lung infection and bacterial clearance rate is better than cefradine.